pmc logo image
Logo of rbejBioMed Central web siteReference to the article.Search.Manuscript submission.Registration.Journal front page.

Formats:

Reprod Biol Endocrinol. 2004; 2: 3.
Published online 2004 January 7. doi: 10.1186/1477-7827-2-3.
PMCID: PMC320497
Syndecans in tumor cell adhesion and signaling
DeannaLee M Beauvais1 and Alan C Rapraegercorresponding author1
1Department of Pathology and Laboratory Medicine, 1300 University Avenue, 6459 Medical Sciences Center (MSC), University of Wisconsin-Madison, Madison, WI 53706-1510, USA
corresponding authorCorresponding author.
DeannaLee M Beauvais: dbeauvais/at/wiscmail.wisc.edu; Alan C Rapraeger: acraprae/at/wiscmail.wisc.edu
Received July 23, 2003; Accepted January 7, 2004.
Abstract
Anchorage of cells to "heparin" – binding domains that are prevalent in extracellular matrix (ECM) components is thought to occur primarily through the syndecans, a four-member family of transmembrane heparan sulfate proteoglycans that communicate environmental cues from the ECM to the cytoskeleton and the signaling apparatus of the cell. Known activities of the syndecans trace to their highly conserved cytoplasmic domains and to their heparan sulfate chains, which can serve to regulate the signaling of growth factors and morphogens. However, several emerging studies point to critical roles for the syndecans' extracellular protein domains in tumor cell behavior to include cell adhesion and invasion. Although the mechanisms of these activities remain largely unknown, one possibility involves "co-receptor" interactions with integrins that may regulate integrin function and the cell adhesion-signaling phenotype. Thus, alterations in syndecan expression, leading to either overexpression or loss of expression, both of which take place in tumor cells, may have dramatic effects on tumor cell invasion.